Anti CD47 Drugs Market is Driven by Immuno-oncology Advances

أضاف وظيفة جديدة Health

2025-05-15 11:32:04 -

The Anti CD47 Drugs Market encompasses innovative therapies designed to block the CD47 “don’t eat me” signal on cancer cells, thereby enabling macrophages and other immune effectors to selectively engulf and destroy malignant cells. Key product offerings include humanized monoclonal antibodies, bispecific antibodies, fusion proteins, and novel antibody fragments that exhibit...

0 التعليقات 0 المشاركات 226 مشاهدة 0 معاينة